Skip to main content

Advertisement

Log in

Crohn’s Disease Only Visible on Small Bowel Capsule Endoscopy: A New Entity

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

A Correction to this article was published on 25 September 2020

This article has been updated

Abstract

Background and Aims

In rare cases, the diagnosis of Crohn’s disease (CD) can only be achieved using small bowel capsule endoscopy (SBCE). We investigate the characteristics of patients with CD only visible on SBCE and assess their disease course.

Methods

Data of all adult patients with confirmed CD diagnosis based on SBCE with normal endoscopic and cross-sectional imaging findings were retrospectively collected in three tertiary-level hospitals from January 2014 to March 2020.

Results

Thirteen patients were included. Ten patients were females, and the mean age at diagnosis was 36 years. Ileum was mostly involved (85%), while duodenum and jejunum were affected in 23% and 38% of the cases, respectively. Nine patients had one segment involved, while four subjects had two or three segments affected. All patients had inflammatory behavior. First treatment consisted of steroids in all cases, and six patients were later treated with immunosuppressant or biologics. After a mean follow-up of 27.5 months, no change in disease behavior, hospitalization, or CD-related surgery was observed.

Conclusions

CD only visible at SBCE is a rare condition with a more favorable disease course compared to general CD with a lower rate of complicated behavior, hospitalization, and surgery, despite a similar use of immunosuppressant or biologics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Change history

Abbreviations

CD:

Crohn’s disease

IBD:

Inflammatory bowel disease

CTE:

Computed tomography enterography

MRE:

Magnetic resonance enterography

US:

Ultrasonography

SBCE:

Small bowel capsule endoscopy

EIMs:

Extra-intestinal manifestations

CECDAI:

Capsule Endoscopy Crohn’s Disease Activity Index

CRP:

C-reactive protein

FC:

Fecal calprotectin

TNF:

Tumor necrosis factor

IMIDS:

Immune-mediated inflammatory disease

References

  1. Torres J, Mehandru S, Colombel JF, et al. Crohn’s disease. Lancet. 2017;389:1741–1755.

    Article  Google Scholar 

  2. Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn Colitis. 2017;11:3–25.

    Article  Google Scholar 

  3. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–297.

    Article  Google Scholar 

  4. Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144–164.

    Article  Google Scholar 

  5. Manes G, Imbesi V, Ardizzone S, et al. Use of double-balloon enteroscopy in the management of patients with Crohn’s disease: feasibility and diagnostic yield in a high-volume centre for inflammatory bowel disease. Surg Endosc. 2009;23:2790–2795.

    Article  Google Scholar 

  6. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature. 2000;405:417.

    Article  CAS  Google Scholar 

  7. Enns RA, Hookey L, Armstrong D, et al. Clinical practice guidelines for the use of video capsule endoscopy. Gastroenterology. 2017;152:497–514.

    Article  Google Scholar 

  8. Hosoe N, Takabayashi K, Ogata H, Kanai T. Capsule endoscopy for small-intestinal disorders: current status. Dig Endosc. 2019;31:498–507.

    Article  Google Scholar 

  9. Long MD, Barnes E, Isaacs K, et al. Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience. Inflamm Bowel Dis. 2011;17:1855–1862.

    Article  Google Scholar 

  10. Sorrentino D, Nguyen V. Clinically significant small bowel Crohn’s disease might only be detected by capsule endoscopy. Inflamm Bowel Dis. 2018;24:1566–1574.

    Article  Google Scholar 

  11. Dionisio PM, Gurudu SR, Leighton JA, et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small bowel Crohn’s disease: a meta-analysis. Am J Gastroenterol. 2010;105:1240–1248.

    Article  Google Scholar 

  12. González-Suárez B, Rodriguez S, Ricart E, et al. Comparison of capsule endoscopy and magnetic resonance enterography for the assessment of small bowel lesions in Crohn’s disease. Inflamm Bowel Dis. 2018;24:775–780.

    Article  Google Scholar 

  13. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–656.

    Article  Google Scholar 

  14. Cosnes J, Bourrier A, Nion-Larmurier I, Sokol H, Beaugerie L, Seksik P. Factors affecting outcomes in Crohn’s disease over 15 years. Gut. 2012;61:1140–1145.

    Article  Google Scholar 

  15. Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn’s disease in a population-based cohort. Dis Colon Rectum. 2012;55:773–777.

    Article  Google Scholar 

  16. Panes J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34:125–145.

    Article  CAS  Google Scholar 

  17. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–1155.

    Article  Google Scholar 

  18. Guizzetti L, Zou G, Khanna R, et al. Development of clinical prediction models for surgery and complications in Crohn’s disease. J Crohns Colitis. 2018;12:167–177.

    Article  Google Scholar 

  19. Chow DK, Sung JJ, Wu JC, et al. Upper gastrointestinal tract phenotype of Crohn’s disease is associated with early surgery and further hospitalization. Inflamm Bowel Dis. 2009;15:551–557.

    Article  Google Scholar 

  20. Lazarev M, Huang C, Bitton A, et al. Relationship between proximal Crohn’s disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol. 2013;108:106–112.

    Article  CAS  Google Scholar 

  21. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–250.

    Article  Google Scholar 

  22. Girelli CM, Porta P, Malacrida V, Barzaghi F, Rocca F. Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn’s disease. Dig Liver Dis. 2007;39:148–154.

    Article  CAS  Google Scholar 

  23. Egea-Valenzuela J, Carrilero-Zaragoza G, Iglesias-Jorquera E, et al. Historical analysis of experience with small bowel capsule endoscopy in a Spanish tertiary hospital. Gastroenterol Hepatol. 2017;40:70–79.

    Article  Google Scholar 

  24. Katsinelos P, Fasoulas K, Beltsis A, et al. Diagnostic yield and clinical impact of wireless capsule endoscopy in patients with chronic abdominal pain with or without diarrhea: a Greek multicenter study. Eur J Intern Med. 2011;22:63–66.

    Article  Google Scholar 

  25. Carretero C, Prieto-Frías C, Muñoz-Navas M. Capsule reading is resources consuming. How can we make the best of it. Rev Esp Enferm Dig. 2015;107:331–333.

    PubMed  Google Scholar 

  26. Egea-Valenzuela J, Suárez B, Bernald C, et al. Development and validation of a scoring index to predict the presence of lesions in capsule endoscopy in patients with suspected Crohn’s disease of the small bowel: a Spanish multicenter study. Eur J Gastroenterol Hepatol. 2018;30:499–505.

    Article  Google Scholar 

  27. Koulaouzidis A, Douglas S, Plevris JN. Lewis score correlates more closely with fecal calprotectin than Capsule Endoscopy Crohn’s Disease Activity Index. Dig Dis Sci. 2012;57:987–993. https://doi.org/10.1007/s10620-011-1956-8.

    Article  PubMed  Google Scholar 

  28. Ponte A, Pinho R, Rodrigues A, et al. Evaluation and comparison of capsule endoscopy scores for assessment of inflammatory activity of small-bowel in Crohn’s disease. Gastroenterol Hepatol. 2018;41:245–250.

    Article  Google Scholar 

  29. Yablecovitch D, Lahat A, Neuman S, et al. The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease? Ther Adv Gastroenterol. 2018;14:11.

    Google Scholar 

  30. Omori T, Kambayashi H, Murasugi S, et al. Comparison of Lewis score and capsule endoscopy Crohn’s disease activity index in patients with Crohn’s disease. Dig Dis Sci. 2020;65:1180–1188. https://doi.org/10.1007/s10620-019-05837-7.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding was received for the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

TC collected the data, wrote the first draft of the article, created tables and figures, and contributed to the editing. FD collected the data and contributed to the editing. CZ and NM contributed to the editing and revised the article for important intellectual content. LPB contributed to editing of the manuscript and supervised the work.

Corresponding author

Correspondence to Laurent Peyrin-Biroulet.

Ethics declarations

Conflict of interest

TC, FD, CZ, and NM have no conflict of interest to disclose. LPB reports personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine; Mylan, Lilly, Fresenius Kabi, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics, Enthera, Theravance; grants from AbbVie, MSD, Takeda; stock options: CTMA.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chateau, T., Damico, F., Zallot, C. et al. Crohn’s Disease Only Visible on Small Bowel Capsule Endoscopy: A New Entity. Dig Dis Sci 66, 2712–2716 (2021). https://doi.org/10.1007/s10620-020-06553-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06553-3

Keywords

Navigation